Foster Wheeler Receives Contract for API Plant Conversion in the U.K.

Foster Wheeler says that one of its global engineering and construction group subsidiaries has been awarded an engineering, procurement, and construction management (EPCM) services contract by Epax Pharma U.K. (Middlesbrough, U.K.), a subsidiary of Trygg Pharma (Oslo). Foster Wheeler will convert parts of the former Lundbeck pharmaceutical plant at Seals Sands, U.K., under the terms of the EPCM services contract, to enable the production of an omega-3 active pharmaceutical ingredient (API) from fish oil. Financial terms of the contract were not disclosed. The...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers